PE-22-28
Also known as: Spadin derivative, TREK-1 antagonist
Synthetic nootropic peptide that enhances cognition through TREK-1 potassium channel inhibition.
Benefits
6
Conditions
5
Evidence
Preclinical animal models of depression and cognition+ studies
Source
Synthetic TREK-1 channel antagonist
Gabriel Brain Score
Strong
Overview
Synthetic nootropic peptide that enhances cognition through TREK-1 potassium channel inhibition.
Mechanism of Action
Potently blocks TREK-1 potassium channels (~100-fold more than spadin), increases neuronal excitability and synaptic transmission, upregulates BDNF expression, promotes hippocampal neurogenesis within 4 days, enhances serotonergic transmission.
Key Benefits
- ✓Rapid cognitive enhancement
- ✓Improves memory and learning
- ✓Reduces depression and anxiety
- ✓Promotes neurogenesis
- ✓Enhances executive function
- ✓Fast-acting (effects within days)
Clinical Applications
Dosing Guidelines
Subcutaneous injection
* Dosing should be individualized. Always consult with a qualified healthcare practitioner.
Research & Evidence
Preclinical animal models of depression and cognition
Strong preclinical evidence for rapid antidepressant and cognitive effects. No human clinical trials. Faster onset than traditional antidepressants in animal models.
Safety Information
Potential Side Effects
- •Unknown in humans
- •Potential overstimulation
Contraindications
- Pregnancy
- Breastfeeding
- Seizure disorders
Interactions
- ⚠Unknown - no human data
Quick Facts
Related Peptides
Dihexa
Potent cognitive enhancer that activates hepatocyte growth factor (HGF) pathway for synaptic plasticity.
Semax
Russian synthetic peptide derived from ACTH with potent nootropic and neuroprotective effects.
Cortexin Derivatives
KhavinsonSynthetic analogs of cortexin bioregulatory peptides with optimized properties for cognitive and neuroprotective applications.